All News
Filter News
Found 809,068 articles
-
Graybug Vision Initiates Clinical Trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion
9/18/2019
Graybug Vision, Inc., a clinical stage pharmaceutical company developing potentially transformative long-acting therapies for ocular diseases including wet age-related macular degeneration (wet AMD), diabetic macular edema (DME), retinal vein occlusion (RVO), and primary open angle glaucoma (POAG), today announced the initiation of its Phase 2a study with GB-102 in patients with macular edema (ME) secondary to DME or RVO.
-
Ceravision Ltd: Ground Breaking Results for New Horticulture Light Technology
9/18/2019
Ceravision Limited, inventor of a new and unique scientific approach to horticulture lighting, today announced the results of trials undertaken over the last six months with a group of leading horticulture businesses.
-
Holly Whitaker Named in Inc.'s 2019 Female Founders 100 List
9/18/2019
Holly Whitaker joins the second annual list of the women building America's most inspiring businesses, along with Rebecca Minkoff, Serena Williams, Audrey Gelman, Rihanna, Alli Webb, and Eileen Fisher.
-
Apollo Endosurgery Receives 510(k) Clearance for Polypropylene Suture-Anchor Assembly
9/18/2019
This proprietary suture-anchor implant is used as part of Apollo’s OverStitch™ and OverStitch Sx™ Endoscopic Suturing Systems to pass and anchor suture in the gastrointestinal tract.
-
OrthoSpin Receives FDA Regulatory Clearance
9/18/2019
OrthoSpin Ltd. a portfolio company of The Trendlines Group Ltd. ("Trendlines") (SGX: 42T) (OTCQX: TRNLY), announced today that it received regulatory clearance from the United States Food and Drug Administration (FDA) for its smart, robotic external fixation system for orthopedic treatments.
-
Anika Commences U.S. Commercial Launch of TACTOSET Bone Repair Therapy Under Its New U.S. Hybrid Commercial Model
9/18/2019
Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated orthopedic medicines company leveraging its proprietary hyaluronic acid ("HA") technology platform to provide therapies across the Joint Preservation and Restoration continuum of care, today announced it has commenced the U.S. commercial soft launch of TACTOSET, its injectable HA-enhanced bone repair therapy
-
Provention Bio Announces Proposed Public Offering of Common Stock - Sept. 18, 2019
9/18/2019
Provention Bio, Inc. announced that it has commenced an underwritten public offering of shares of its common stock.
-
CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) Inhibitors Market 2019-2023 - Evolving Opportunities with Bristol-Myers Squibb Co. and AstraZeneca Plc - Technavio
9/18/2019
The global CTLA4 (Cytotoxic T-Lymphocyte-Associated Protein 4) market size will grow by USD 720.39 million during 2019-2023. This market report provides a detailed analysis of the market by type (monotherapy and combination therapy) and geography (Asia, Europe, North America, and ROW).
-
DarioHealth Awarded U.S. Patent for Optical Transmission of Data Between a Sensor and Smart Device
9/18/2019
DarioHealth Corp. ("DarioHealth" or "Dario") (Nasdaq: DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled "Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.
-
Alan J. Bauman, MD, ABHRS, IAHRS, Receives "#1 Top Hair Restoration Surgeon" and "Top 100 Aesthetic Doctors" in the Aesthetic Everything® 2019 Aesthetic and Cosmetic Medicine Awards
9/18/2019
Voting was held online between April 1st and April 27th, 2019.
-
Wounded Warrior Project Renews Partnership with Vail Veterans Program
9/18/2019
Their therapeutic programs enhance rehabilitation by building lifelong skill sets including emotional stability, resilience, independence, and health and wellness practices.
-
Nacho Abia of Olympus Corporation of the Americas Joins More Than 700 CEOs in Unprecedented Commitment to Advance Diversity and Inclusion in the Workplace
9/18/2019
Olympus Commits to Open Dialogue, Unconscious Bias Education, Collaboration with Other Corporate Leaders and the Creation of Strategic Diversity and Inclusion Paths
-
Kinston Community Health Center Used NextGen Healthcare Solution to Prepare Patients Ahead of Hurricane Dorian’s Landfall
9/18/2019
Patients contacted via email and text with crucial information regarding medications and medical supplies in advance of hurricane
-
Information Update - Health Canada seized multiple unauthorized health products from three stores in Ontario and one in Quebec because they may pose serious health risks
9/18/2019
Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.
-
Toyobo to market RNA Analysis Kit based on RIKEN technology to help develop genomic medicine
9/18/2019
The Laboratory for Bioinformatics Research at the RIKEN Center for Biosystems Dynamics Research developed this method last year.
-
League Wins HRD Readers' Choice Award For Best Service Provider At The 2019 Canadian HR Awards
9/18/2019
Industry Innovator recognized for outstanding contributions to the HR profession and for championing digital benefits in Canada
-
How Will IoT Revolutionize Pharmaceutical Manufacturing? Read Infiniti’s Latest Blog for More Insights
9/18/2019
In this article, experts at Infiniti provide a detailed look at how IoT will transform pharmaceutical manufacturing.
-
X4 Pharmaceuticals Appoints Renato Skerlj, Ph.D. as Senior Vice President of Research and Development
9/18/2019
X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for the treatment of rare diseases, today announced the appointment of Renato Skerlj, Ph.D., as Senior Vice President, Research and Development.
-
Rodrigo Bianchi Appointed as New LimaCorporate Advisory Board Member
9/18/2019
LimaCorporate is pleased to announce that Rodrigo Bianchi will join the LimaCorporate Advisory Board.
-
Kraig Biocraft Laboratories Announces First New Member of Expanded Board of Directors
9/18/2019
Kraig Biocraft Laboratories, Inc., the leading developer of spider silk based fibers, announces that it has selected Mr. Anurag Gupta for its expanded Board of Directors.